Scrotal cancer: incidence, survival and second primary tumours in the Netherlands since 1989
BACKGROUND: Since the 1970s there have been few epidemiological studies of scrotal cancer. We report on the descriptive epidemiology of scrotal cancer in the Netherlands. METHODS: Data on all scrotal cancer patients were obtained from the Netherlands Cancer Registry (NCR) in the period 1989-2006 and age-standardised incidence rates were calculated also according to histology and stage. Relative survival was calculated and multiple primary tumours were studied. RESULTS: The overall incidence rate varied around 1.5 per 1 000 000 person-years, most frequently being squamous cell carcinoma (27%),... Mehr ...
| Verfasser: | |
|---|---|
| Dokumenttyp: | Artikel |
| Erscheinungsdatum: | 2010 |
| Reihe/Periodikum: | Verhoeven , RHA , Louwman , W , Koldewijn , EL , Demeyere , TBJ & Coebergh , J W 2010 , ' Scrotal cancer: incidence, survival and second primary tumours in the Netherlands since 1989 ' , British Journal of Cancer , vol. 103 , no. 9 , pp. 1462-1466 . https://doi.org/10.1038/sj.bjc.6605914 |
| Schlagwörter: | /dk/atira/pure/keywords/researchprograms/AFL001000/EMCNIHES026502 / name=EMC NIHES-02-65-02 / /dk/atira/pure/sustainabledevelopmentgoals/good_health_and_well_being / name=SDG 3 - Good Health and Well-being |
| Sprache: | unknown |
| Permalink: | https://search.fid-benelux.de/Record/base-27224796 |
| Datenquelle: | BASE; Originalkatalog |
| Powered By: | BASE |
| Link(s) : | https://pure.eur.nl/en/publications/1942a49d-f339-488b-88ac-4cf35c4fbe14 |
BACKGROUND: Since the 1970s there have been few epidemiological studies of scrotal cancer. We report on the descriptive epidemiology of scrotal cancer in the Netherlands. METHODS: Data on all scrotal cancer patients were obtained from the Netherlands Cancer Registry (NCR) in the period 1989-2006 and age-standardised incidence rates were calculated also according to histology and stage. Relative survival was calculated and multiple primary tumours were studied. RESULTS: The overall incidence rate varied around 1.5 per 1 000 000 person-years, most frequently being squamous cell carcinoma (27%), basal cell carcinoma (19%) and Bowen's disease (15%). Overall 5-year relative survival was 82%, being 77% and 95% for patients with squamous and basal cell carcinoma, respectively. In all, 18% of the patients were diagnosed with a second primary tumour. CONCLUSION: The incidence rate of scrotal cancer did not decrease, although this was expected; affected patients might benefit from regular checkups for possible new cancers. British Journal of Cancer (2010) 103, 1462-1466. doi:10.1038/sj.bjc.6605914 www.bjcancer.com Published online 28 September 2010 (C) 2010 Cancer Research UK